Dental Care Clinics in Tuckahoe, NY Accepting Medicare
4 Dental Care Clinics found. Showing 1 - 4
 Davis Dental Pllc Clinic/Center - Dental Medicare: Medicare Enrolled Practice Location: 300 Columbus Ave Ste C, Tuckahoe, NY 10707 Phone: 914-533-4200 Fax: 914-533-4202 |
Crestwood Dental Services,p.c. Dentist Medicare: Not Enrolled in Medicare Practice Location: 40 Fisher Ave, Tuckahoe, NY 10707 Phone: 914-793-4411 Fax: 914-793-6949 |
Planet Smile Partners Main Street Dentistry Pllc Dentist - Orthodontics and Dentofacial Orthopedics Medicare: Not Enrolled in Medicare Practice Location: 115 Main St Ste 200, Tuckahoe, NY 10707 Phone: 914-864-0464 |
Evenly Dentistry North, Pc Dentist - Orthodontics and Dentofacial Orthopedics Medicare: Not Enrolled in Medicare Practice Location: 64 Midland Pl Apt 2404, Tuckahoe, NY 10707 Phone: 800-500-0493 |
News Archive
Admin, Dems face challenge in showing voters what reform means for them
As health reform proposals emerge from congressional committees, partisan fighting boils and the president wades into the debate with a series of televised addresses, news reports turn to an unanswered question. "What's in it for me?" asks David Leonhardt, the New York Times business columnist. "On the subject of health care reform, most Americans probably don't have a good answer to the question. And that, obviously, is a problem for the White House and for Democratic leaders in Congress," he writes.
Analysis looks at how Democrats won health reform battle
In an analysis in The New Republic, Jonathan Cohn examines how Democrats ultimately won the health reform battle. "Of course, we know how this narrative concludes, with Obama sitting in the East Room, inscribing his signature onto the Patient Protection and Affordable Care Act of 2010 — completing a quest that eluded Harry Truman and a trio of his successors.
NIH awards DiscoveryBioMed grant to develop therapies for cystic fibrosis
DiscoveryBioMed, Inc. (DBM) today announced that it has been awarded a Phase 1 Small Business Innovation Research (SBIR) grant by the National Institutes of Health (NIH). The $308,000 grant will be used to advance certain small molecule drug discovery programs designed to correct the genetic mutation most common to cystic fibrosis (CF).
Research finding could help predict the next outbreak of plague
Biologists at the University of Oslo, Norway, are now making a giant effort to identify the relationship between climate change, rat infestations, and the many major plague epidemics throughout history. The knowledge may be used to predict the next plague outbreak.
EMPA-REG OUTCOME trial demonstrates superiority of Jardiance in T2D patients at risk for CV events
Boehringer Ingelheim and Eli Lilly and Company today announced positive top-line results from EMPA-REG OUTCOME. This is a long-term clinical trial investigating cardiovascular (CV) outcomes for Jardiance (empagliflozin) in more than 7,000 adults with type 2 diabetes (T2D) at high risk for CV events.
› Verified 4 days ago